Institute for Wealth Management LLC. Sells 120 Shares of VanEck Biotech ETF (NASDAQ:BBH)

Institute for Wealth Management LLC. cut its position in shares of VanEck Biotech ETF (NASDAQ:BBH) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,678 shares of the company’s stock after selling 120 shares during the period. Institute for Wealth Management LLC. owned about 0.27% of VanEck Biotech ETF worth $1,269,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Private Advisor Group LLC increased its position in shares of VanEck Biotech ETF by 4.7% during the third quarter. Private Advisor Group LLC now owns 1,675 shares of the company’s stock valued at $261,000 after purchasing an additional 75 shares during the period. Ameriprise Financial Inc. raised its stake in VanEck Biotech ETF by 1.2% during the third quarter. Ameriprise Financial Inc. now owns 6,547 shares of the company’s stock worth $1,020,000 after acquiring an additional 79 shares in the last quarter. Advisor Group Holdings Inc. raised its stake in VanEck Biotech ETF by 6.8% during the fourth quarter. Advisor Group Holdings Inc. now owns 2,291 shares of the company’s stock worth $366,000 after acquiring an additional 146 shares in the last quarter. Anchor Investment Management LLC acquired a new position in VanEck Biotech ETF during the fourth quarter worth $26,000. Finally, MML Investors Services LLC raised its stake in VanEck Biotech ETF by 4.5% during the first quarter. MML Investors Services LLC now owns 4,586 shares of the company’s stock worth $743,000 after acquiring an additional 199 shares in the last quarter. 32.05% of the stock is currently owned by institutional investors.

VanEck Biotech ETF Trading Up 0.2 %

VanEck Biotech ETF stock opened at $152.36 on Friday. The stock has a fifty day moving average price of $162.68 and a two-hundred day moving average price of $159.71. VanEck Biotech ETF has a 52-week low of $142.51 and a 52-week high of $171.04.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.